These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7019616)

  • 1. Augmentation by naloxone of efflux of LRF from superfused medial basal hypothalamus.
    Wilkes MM; Yen SS
    Life Sci; 1981 May; 28(21):2355-9. PubMed ID: 7019616
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of morphine on the basal and the dopamine-induced release of LHRH from mediobasal hypothalamic fragments in vitro.
    Rotsztejn WH; Drouva SV; Pattou E; Kordon C
    Eur J Pharmacol; 1978 Aug; 50(3):285-6. PubMed ID: 357165
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of aging on the in vitro release of gonadotropin-releasing hormone.
    Jarjour LT; Handelsman DJ; Swerdloff RS
    Endocrinology; 1986 Sep; 119(3):1113-7. PubMed ID: 3089764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction by beta-endorphin of efflux of dopamine and DOPAC from superfused medial basal hypothalamus.
    Wilkes MM; Yen SS
    Life Sci; 1980 Oct; 27(15):1387-91. PubMed ID: 6255276
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of intrahypothalamic testosterone implants on LHRH levels in the preoptic area and the medial basal hypothalamus.
    Kalra PS; Kalra SP
    Life Sci; 1978 Jul; 23(1):65-8. PubMed ID: 355756
    [No Abstract]   [Full Text] [Related]  

  • 6. The N-methyl-D-aspartate-mediated inhibitory control of gonadotropin-releasing hormone release in the hypothalamus of the adult male guinea pig is expressed through opioidergic systems.
    Giri M; Gao C; Kaufman JM
    Endocrinology; 1996 Apr; 137(4):1468-73. PubMed ID: 8625925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioidergic modulation of in vitro pulsatile gonadotropin-releasing hormone release from the isolated medial basal hypothalamus of the male guinea pig.
    Giri M; Kaufman JM
    Endocrinology; 1994 Nov; 135(5):2137-43. PubMed ID: 7956937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the origin of luteinizing hormone-releasing hormone (LH-RH) in the supraoptic crest.
    Brownstein MJ; Palkovits M; Kizer JS
    Life Sci; 1975 Sep; 17(5):679-82. PubMed ID: 54859
    [No Abstract]   [Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone release by superfused hypothalami in response to norepinephrine.
    Nowak FV; Swerdloff RS
    Biol Reprod; 1985 Nov; 33(4):790-6. PubMed ID: 3910121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the pineal gland on LH-RH and FSH-RH activity in the medial basal hypothalamus of the male golden hamster.
    Blask DE; Reiter RJ; Vaughan MK; Johnson LY
    Neuroendocrinology; 1979; 28(1):36-43. PubMed ID: 372837
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro effects of a synethetic enkephalin analogue (D-Met2,Pro5)-enkephalinamide on the hypothalamus-pituitary--testis function in rats.
    Vermes I; Szontágh L; Telegdy G
    Neurosci Lett; 1979 Feb; 11(2):201-4. PubMed ID: 379712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone blocks dopamine-mediated release of gonadotropins in rat hypothalamus.
    Singh HH; Purohit V; Ahluwalia BS
    Neuroendocrinology; 1982; 34(5):347-52. PubMed ID: 7043300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal changes in medial basal hypothalamic LH-RH correlated with plasma LH during the rat estrous cycle and following electrochemical stimulation of the medial preoptic area in pentobarbital-treated proestrous rats.
    Barr GD; Barraclough CA
    Brain Res; 1978 Jun; 148(2):413-23. PubMed ID: 350353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by morphine and beta-endorphin of vasopressin release evoked by electrical stimulation of the rat medial basal hypothalamus in vitro.
    Knepel W; Reimann W
    Brain Res; 1982 Apr; 238(2):484-8. PubMed ID: 6284302
    [No Abstract]   [Full Text] [Related]  

  • 15. Ascorbic acid enhances the release of luteinizing hormone-releasing hormone from the mediobasal hypothalamus in vitro.
    Miller BT; Cicero TJ
    Life Sci; 1986 Dec; 39(25):2447-54. PubMed ID: 3099112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous opioid regulation of gonadotropin-releasing hormone release from the human fetal hypothalamus in vitro.
    Rasmussen DD; Liu JH; Wolf PL; Yen SS
    J Clin Endocrinol Metab; 1983 Nov; 57(5):881-4. PubMed ID: 6311863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An opioid-neuropeptide-Y transmission line to luteinizing hormone (LH)-releasing hormone neurons: a role in the induction of LH surge.
    Sahu A; Crowley WR; Kalra SP
    Endocrinology; 1990 Feb; 126(2):876-83. PubMed ID: 2404749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in photoperiod alter the daily rhythms of pineal melatonin content and hypothalamic beta-endorphin content and the luteinizing hormone response to naloxone in the male Syrian hamster.
    Roberts AC; Martensz ND; Hastings MH; Herbert J
    Endocrinology; 1985 Jul; 117(1):141-8. PubMed ID: 3159563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in the responses of hypothalamic luteinizing hormone-releasing hormone and catecholamine systems to ovarian hormones and naloxone: implications for sexual differentiation of luteinizing hormone secretion in rats.
    Crowley WR
    Brain Res; 1988 Oct; 461(2):314-21. PubMed ID: 3052697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vitro stimulation by naloxone and K+ of luteinizing hormone-releasing hormone and catecholamine release from the hypothalami of intact and castrated rats.
    Kalra PS; Crowley WR; Kalra SP
    Endocrinology; 1987 Jan; 120(1):178-85. PubMed ID: 3536452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.